| Literature DB >> 28572392 |
Stephen K Murphy1, Mingshuo Zeng1, Seth B Herzon2,3.
Abstract
The tricyclic diterpene fungal metabolite (+)-pleuromutilin has served as a starting point for antibiotic development. Semisynthetic modification of its glycolic acid subunit at C14 provided the first analogs fit for human use, and derivatization at C12 led to 12-epi-pleuromutilins with extended-spectrum antibacterial activity, including activity against Gram-negative pathogens. Given the inherent limitations of semisynthesis, however, accessing derivatives of (+)-pleuromutilin with full control over their structure presents an opportunity to develop derivatives with improved antibacterial activities. Here we disclose a modular synthesis of pleuromutilins by the convergent union of an enimide with a bifunctional iodoether. We illustrate our approach through synthesis of (+)-12-epi-mutilin, (+)-11,12-di-epi-mutilin, (+)-12-epi-pleuromutilin, (+)-11,12-di-epi-pleuromutilin, and (+)-pleuromutilin itself in 17 to 20 steps.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28572392 PMCID: PMC7001679 DOI: 10.1126/science.aan0003
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728